Astellas Pharma Inc.

4503.T · Moat type: REGULIERUNG

MoatScore

7/10

Fair Value

4,786 JPY (≈ 29.67 USD)

Margin of Safety

+55.2 %

Rating

STARK

GESCHÄFTSMODELL Astellas Pharma Inc. is a Japanese pharmaceutical manufacturer that generates revenues primarily through the development, production, and global marketing of prescription pharmaceuticals—particularly in the fields of oncology, urology, transplantation, and neurology—whereby patent protection and regulatory approvals constitute the central barriers to entry for competitors.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.